Palatin Technologies
PTN
#10749
Rank
C$19.19 M
Marketcap
C$10.79
Share price
-1.41%
Change (1 day)
N/A
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2026 (TTM): -C$8.46 Million

According to Palatin Technologies's latest financial reports the company's current earnings are C$12.88 Million. In 2025 the company made an earning of -C$13.48 Million, an increase over its 2024 earnings that were of -C$37.75 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$8.46 Million-37.3%
2025 -C$13.48 Million-64.29%
2024 -C$37.75 Million-16.9%
2023 -C$45.43 Million5.99%
2022 -C$42.86 Million-13.7%
2021 -C$49.66 Million33.25%
2020 -C$37.27 Million-172.11%
2019 C$51.68 M2352.33%
2018 C$2.1 M-94.13%
2017 C$35.91 M-154.92%
2016 -C$65.39 Million3.67%
2015 -C$63.07 Million878%
2014 -C$6.45 Million-72.64%
2013 -C$23.58 Million-33.11%
2012 -C$35.24 Million77.71%
2011 -C$19.83 Million
2003 -C$33.58 Million29.93%
2002 -C$25.85 Million36.18%
2001 -C$18.98 Million
1999 -C$15.75 Million6.04%
1998 -C$14.86 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$36.40 B-416,306.07%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$20.54 B-235,029.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
C$1.11 B-12,897.47%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-C$16.42 Million 87.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
C$0.26 B-3,151.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-C$0.17 Billion 1,784.89%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
C$0.16 B-1,958.82%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-C$41.32 Million 372.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-C$81.19 Million 828.28%๐Ÿ‡บ๐Ÿ‡ธ USA